HIV Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

National HIV Testing Day 2026: From Lab-Based Tests to Self-Testing

Idvynso, Merck’s Once-Daily HIV Pill, Wins FDA Approval

World AIDS Vaccine Day 2026: What HIV Vaccine Research Is Testing Now

Top 20 Best-Selling Infectious Disease Drugs Dominating in 2025

September 11, 2025

Gilead’s Yeztugo Becomes First FDA-Approved Twice-Yearly HIV Prevention Shot

National HIV Testing Day 2025: Self-Love Meets Health Awareness and HIV Prevention

World AIDS Vaccine Day 2025: Innovations Face Real-World Challenges

Top 10 Best-Selling Infectious Disease Drugs Based on Recent Sales Data

February 11, 2025

World AIDS Day 2024: Take the Rights Path

November 27, 2024

World AIDS Vaccine Day 2024: Prospects in HIV Vaccine Research

World AIDS Day 2023: New and Promising Treatments for HIV/AIDS

November 30, 2023

HIV Vaccine Trial of Vir Biotech’s New Candidate VIR-1388 Begins

September 21, 2023

Sunlenca (lenacapavir) Receives FDA Approval as HIV Treatment Option for Multi-Drug Resistant Infection

January 9, 2023

Gilead’s Long-Term Real-World Data Show HIV Drug Biktarvy Has High, Sustained Efficacy

October 26, 2022

Sunlenca, Gilead’s Long-Acting HIV Treatment, Secures Authorization in the EU

August 29, 2022

Clinical Trial News

Lenacapavir, Gilead’s Investigational HIV Drug, Gets Its Clinical Hold Lifted By the FDA

Next Page »